Biolife Solutions (BLFS) Total Non-Current Liabilities (2010 - 2026)
Biolife Solutions (BLFS) reported Total Non-Current Liabilities of $28.5 million for Q1 2026, down 15.76% quarter-over-quarter from $33.8 million in Q4 2025.
Biolife Solutions (BLFS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of Total Non-Current Liabilities data on file, last reported at $28.5 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $28.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $28.5 million (changed N/A YoY), and the FY2025 annual result was $33.8 million, down 33.12% from the prior year.
- Total Non-Current Liabilities fell to $28.5 million in Q1 2026 per BLFS's latest filing, from $33.8 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $86.5 million in Q1 2023 and troughed at $28.5 million in Q1 2026.
- A 5-year average of $65.7 million and a median of $75.1 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities soared 115.4% in 2022, then sank 33.12% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $86.0 million in 2022, then dropped by 12.76% to $75.1 million in 2023, then plunged by 32.61% to $50.6 million in 2024, then tumbled by 33.12% to $33.8 million in 2025, then slipped by 15.76% to $28.5 million in 2026.
- Business Quant data shows BLFS's Total Non-Current Liabilities at $28.5 million in Q1 2026, $33.8 million in Q4 2025, and $50.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | 28.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.49 Mn |
| Dec 31, 2025 | 33.83 Mn |
| Dec 31, 2024 | 50.58 Mn |
| Dec 31, 2023 | 75.05 Mn |
| Sep 30, 2023 | 79.14 Mn |
| Jun 30, 2023 | 79.14 Mn |
| Mar 31, 2023 | 86.48 Mn |
| Dec 31, 2022 | 86.03 Mn |
| Sep 30, 2022 | 79.71 Mn |
| Jun 30, 2022 | 59.23 Mn |
| Mar 31, 2022 | 65.20 Mn |
| Dec 31, 2021 | 76.20 Mn |
| Sep 30, 2021 | 64.61 Mn |
| Jun 30, 2021 | 63.16 Mn |
| Mar 31, 2021 | 30.27 Mn |
| Dec 31, 2020 | 29.51 Mn |
| Sep 30, 2020 | 8.77 Mn |
| Jun 30, 2020 | 7.74 Mn |
| Mar 31, 2020 | 25.38 Mn |
| Dec 31, 2019 | 49.36 Mn |